Showing results (201-210 of 1,348) with videos related to
Sort By:
Pageof 135
Clinical Pharmacology in Drug Development|May 7, 2019
Effects of Differential Food Patterns on the Pharmacokinetics of Enteric-Coated Mesalazine Tablets in the Same Cohort of Healthy Chinese VolunteersSu-Hua Zhang, Yao Li, Shan-Shan Wei, et al.Clinical Pharmacology in Drug Development|September 20, 2018
Effect of a High-Fat Meal on the Pharmacokinetics of the HIV Integrase Inhibitor CabotegravirParul Patel, Susan L Ford, Yu Lou, et al.Clinical Pharmacology in Drug Development|October 10, 2019
Open-Label, Randomized, Single-Dose, 2-Period, 2-Sequence Crossover, Comparative Pharmacokinetic Study to Evaluate Bioequivalence of 2 Oral Formulations of Olanzapine Under Fasting and Fed ConditionsPing Du, Pengfei Li, Hongchuan Liu, et al.Clinical Pharmacology in Drug Development|September 27, 2018
A Phase 1 Assessment of the QT Interval in Healthy Adults Following Exposure to Rolapitant, a Cancer Supportive Care AntiemeticXiaodong Wang, Zhi-Yi Zhang, Jing Wang, et al.Clinical Pharmacology in Drug Development|August 23, 2016
Effect of Food and Esomeprazole on the Pharmacokinetics of Alectinib, a Highly Selective ALK Inhibitor, in Healthy SubjectsPeter N Morcos, Elena Guerini, Neil Parrott, et al.Clinical Pharmacology in Drug Development|August 23, 2016
Effect of the Wetting Agent Sodium Lauryl Sulfate on the Pharmacokinetics of Alectinib: Results From a Bioequivalence Study in Healthy SubjectsPeter N Morcos, Neil Parrott, Ludger Banken, et al.Clinical Pharmacology in Drug Development|May 3, 2023
Pharmacokinetics and Bioequivalence of 2 Nifedipine Controlled-Release Tablets: A Randomized, Single-Dose, 2-Period Crossover Study in Healthy Chinese Volunteers Under Fasting and Fed ConditionsLiang Xin, Qing Chen, Dandan Chen, et al.Clinical Pharmacology in Drug Development|May 3, 2023
Disposition and Mass Balance of Etrasimod in Healthy Subjects and In Vitro Determination of the Enzymes Responsible for Its Oxidative MetabolismCaroline A Lee, D Alexander Oh, Yong Tang, et al.Clinical Pharmacology in Drug Development|May 3, 2023
Evaluation of the Cytochrome P450 3A and P-glycoprotein Drug-Drug Interaction Potential of FutibatinibIkuo Yamamiya, Allen Hunt, Toru Takenaka, et al.Clinical Pharmacology in Drug Development|August 22, 2020
Phase 1 Studies to Define the Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Profiles of the Nonsteroidal Mineralocorticoid Receptor Antagonist Apararenone in Healthy VolunteersTadakatsu Nakamura, Atsuhiro KawaguchiPageof 135